about
Statin drug interactions and related adverse reactions.The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population.HIV stroke risk: evidence and implications.Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES.Changes in coronary heart disease risk profiles of HIV patients in Zimbabwe over 9 months: a follow-up study.Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects.Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks.Management of lipid disorders in patients living with HIV.
P2860
Q34292468-87094E14-2940-4BEA-8F11-C6994464A8CCQ35114120-B918AEF8-1325-407D-997C-60369BA49850Q36722756-139484A4-F743-4266-AAD5-7576A555526AQ36974022-D0EB2D23-FAF2-4BAE-8ACF-CA6981BB320FQ37381433-8D4B2F2B-B1F3-4C38-AB34-2D11E1CB5414Q37418053-9E33C1EB-017D-4883-81FF-B79B9212C42AQ37691625-B5079780-E449-41D1-8EF1-9987FDF263C1Q38344129-004D9BED-40E9-45DA-B4F9-D8781769B88C
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Management of dyslipidemia in HIV-infected patients.
@ast
Management of dyslipidemia in HIV-infected patients.
@en
type
label
Management of dyslipidemia in HIV-infected patients.
@ast
Management of dyslipidemia in HIV-infected patients.
@en
prefLabel
Management of dyslipidemia in HIV-infected patients.
@ast
Management of dyslipidemia in HIV-infected patients.
@en
P2860
P356
P1433
P1476
Management of dyslipidemia in HIV-infected patients.
@en
P2093
Carlos D Malvestutto
Judith A Aberg
P2860
P304
P356
10.2217/CLP.11.25
P577
2011-08-01T00:00:00Z